Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
4066 | 1853 | 38.4 | 82% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
159 | 3 | MENOPAUSE//ISOFLAVONES//TAMOXIFEN | 61134 |
558 | 2 | MENOPAUSE//HORMONE REPLACEMENT THERAPY//MATURITAS | 14547 |
4066 | 1 | HORMONE REPLACEMENT THERAPY//HORMONE THERAPY//WOMENS HEALTH INITIATIVE | 1853 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | HORMONE REPLACEMENT THERAPY | authKW | 1005529 | 22% | 15% | 399 |
2 | HORMONE THERAPY | authKW | 762905 | 14% | 18% | 259 |
3 | WOMENS HEALTH INITIATIVE | authKW | 488992 | 3% | 46% | 64 |
4 | CLIMACTERIC | journal | 312897 | 8% | 13% | 142 |
5 | MENOPAUSE | authKW | 303344 | 20% | 5% | 362 |
6 | MENOPAUSAL HORMONE THERAPY | authKW | 263586 | 2% | 40% | 40 |
7 | POSTMENOPAUSAL HORMONE THERAPY | authKW | 226173 | 2% | 44% | 31 |
8 | BIOIDENTICAL HORMONES | authKW | 189967 | 1% | 82% | 14 |
9 | PROGESTOGENS | authKW | 125546 | 4% | 12% | 65 |
10 | MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY | journal | 123682 | 7% | 6% | 130 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Obstetrics & Gynecology | 35518 | 42% | 0% | 775 |
2 | Geriatrics & Gerontology | 4716 | 9% | 0% | 163 |
3 | Medicine, General & Internal | 2038 | 17% | 0% | 306 |
4 | Peripheral Vascular Diseases | 1119 | 8% | 0% | 146 |
5 | Women’s Studies | 976 | 2% | 0% | 42 |
6 | Endocrinology & Metabolism | 700 | 9% | 0% | 160 |
7 | Reproductive Biology | 591 | 4% | 0% | 71 |
8 | Public, Environmental & Occupational Health | 573 | 8% | 0% | 157 |
9 | Oncology | 491 | 10% | 0% | 193 |
10 | Cardiac & Cardiovascular System | 430 | 7% | 0% | 134 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CARDIOVASC EPIDEMIOL SECT | 82386 | 0% | 100% | 5 |
2 | ENDOCRINOL MENOPAUSE | 62423 | 1% | 32% | 12 |
3 | DANISH NURSE COHORT | 49431 | 0% | 100% | 3 |
4 | WHI PROJECT OFF | 37072 | 0% | 75% | 3 |
5 | CARDIOVASC EPIDEMIOL UNIT U258 | 32954 | 0% | 100% | 2 |
6 | DANISH NURSE STUDY | 32954 | 0% | 100% | 2 |
7 | GRP GYNECOLOGISTS OBSTETRICIANS GENEVA | 32954 | 0% | 100% | 2 |
8 | KLIN MENOPAUZY CHOROB KOBIECYCH | 32954 | 0% | 100% | 2 |
9 | MED INTERNA SUR | 32954 | 0% | 100% | 2 |
10 | RED ESPANOLA INVEST CARDIOVASC RD 12 0042 0008 | 32954 | 0% | 100% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CLIMACTERIC | 312897 | 8% | 13% | 142 |
2 | MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY | 123682 | 7% | 6% | 130 |
3 | MATURITAS | 99593 | 8% | 4% | 147 |
4 | PRZEGLAD MENOPAUZALNY | 14236 | 1% | 4% | 21 |
5 | GYNECOLOGICAL ENDOCRINOLOGY | 6325 | 2% | 1% | 34 |
6 | JOURNAL OF WOMENS HEALTH | 5981 | 2% | 1% | 28 |
7 | GEBURTSHILFE UND FRAUENHEILKUNDE | 1875 | 1% | 0% | 24 |
8 | INTERNATIONAL JOURNAL OF FERTILITY AND WOMENS MEDICINE | 1627 | 0% | 2% | 6 |
9 | ZDRAVNISKI VESTNIK-SLOVENIAN MEDICAL JOURNAL | 1515 | 0% | 1% | 8 |
10 | BREAST CANCER RESEARCH AND TREATMENT | 1380 | 1% | 0% | 25 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | HORMONE REPLACEMENT THERAPY | 1005529 | 22% | 15% | 399 | Search HORMONE+REPLACEMENT+THERAPY | Search HORMONE+REPLACEMENT+THERAPY |
2 | HORMONE THERAPY | 762905 | 14% | 18% | 259 | Search HORMONE+THERAPY | Search HORMONE+THERAPY |
3 | WOMENS HEALTH INITIATIVE | 488992 | 3% | 46% | 64 | Search WOMENS+HEALTH+INITIATIVE | Search WOMENS+HEALTH+INITIATIVE |
4 | MENOPAUSE | 303344 | 20% | 5% | 362 | Search MENOPAUSE | Search MENOPAUSE |
5 | MENOPAUSAL HORMONE THERAPY | 263586 | 2% | 40% | 40 | Search MENOPAUSAL+HORMONE+THERAPY | Search MENOPAUSAL+HORMONE+THERAPY |
6 | POSTMENOPAUSAL HORMONE THERAPY | 226173 | 2% | 44% | 31 | Search POSTMENOPAUSAL+HORMONE+THERAPY | Search POSTMENOPAUSAL+HORMONE+THERAPY |
7 | BIOIDENTICAL HORMONES | 189967 | 1% | 82% | 14 | Search BIOIDENTICAL+HORMONES | Search BIOIDENTICAL+HORMONES |
8 | PROGESTOGENS | 125546 | 4% | 12% | 65 | Search PROGESTOGENS | Search PROGESTOGENS |
9 | WHI | 112328 | 1% | 45% | 15 | Search WHI | Search WHI |
10 | PROGESTIN | 107578 | 5% | 8% | 85 | Search PROGESTIN | Search PROGESTIN |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | HALE, GE , SHUFELT, CL , (2015) HORMONE THERAPY IN MENOPAUSE: AN UPDATE ON CARDIOVASCULAR DISEASE CONSIDERATIONS.TRENDS IN CARDIOVASCULAR MEDICINE. VOL. 25. ISSUE 6. P. 540 -549 | 59 | 75% | 5 |
2 | ROSSOUW, JE , ANDERSON, GL , PRENTICE, RL , LACROIX, AZ , KOOPERBERG, C , STEFANICK, ML , JACKSON, RD , BERESFORD, SAA , HOWARD, BV , JOHNSON, KC , ET AL (2002) RISKS AND BENEFITS OF ESTROGEN PLUS PROGESTIN IN HEALTHY POSTMENOPAUSAL WOMEN - PRINCIPAL RESULTS FROM THE WOMEN'S HEALTH INITIATIVE RANDOMIZED CONTROLLED TRIAL.JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. VOL. 288. ISSUE 3. P. 321 -333 | 22 | 56% | 7989 |
3 | BASSUK, SS , MANSON, JE , (2014) MENOPAUSAL HORMONE THERAPY AND CARDIOVASCULAR DISEASE RISK: UTILITY OF BIOMARKERS AND CLINICAL FACTORS FOR RISK STRATIFICATION.CLINICAL CHEMISTRY. VOL. 60. ISSUE 1. P. 68-77 | 43 | 91% | 13 |
4 | SIMON, JA , (2014) WHAT IF THE WOMEN'S HEALTH INITIATIVE HAD USED TRANSDERMAL ESTRADIOL AND ORAL PROGESTERONE INSTEAD?.MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY. VOL. 21. ISSUE 7. P. 769 -783 | 56 | 72% | 5 |
5 | JONES, ME , SCHOEMAKER, MJ , WRIGHT, L , MCFADDEN, E , GRIFFIN, J , THOMAS, D , HEMMING, J , WRIGHT, K , ASHWORTH, A , SWERDLOW, AJ , (2016) MENOPAUSAL HORMONE THERAPY AND BREAST CANCER: WHAT IS THE TRUE SIZE OF THE INCREASED RISK?.BRITISH JOURNAL OF CANCER. VOL. 115. ISSUE 5. P. 607 -615 | 41 | 84% | 2 |
6 | ANTOINE, C , AMEYE, L , PAESMANS, M , ROZENBERG, S , (2014) SYSTEMATIC REVIEW ABOUT BREAST CANCER INCIDENCE IN RELATION TO HORMONE REPLACEMENT THERAPY USE.CLIMACTERIC. VOL. 17. ISSUE 2. P. 116-132 | 53 | 72% | 5 |
7 | BOARDMAN, HMP , HARTLEY, L , EISINGA, A , MAIN, C , FIGULS, MRI , COSP, XB , SANCHEZ, R , KNIGHT, B , (2015) HORMONE THERAPY FOR PREVENTING CARDIOVASCULAR DISEASE IN POST-MENOPAUSAL WOMEN.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 3. P. - | 61 | 43% | 28 |
8 | BRINTON, LA , RICHESSON, D , LEITZMANN, MF , GIERACH, GL , SCHATZKIN, A , MOUW, T , HOLLENBECK, AR , LACEY, JV , (2008) MENOPAUSAL HORMONE THERAPY AND BREAST CANCER RISK IN THE NIH-AARP DIET AND HEALTH STUDY COHORT.CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. VOL. 17. ISSUE 11. P. 3150-3160 | 45 | 88% | 41 |
9 | TAYLOR, HS , KAGAN, R , ALTOMARE, CJ , CORT, S , BUSHMAKIN, AG , ABRAHAM, L , (2017) KNOWLEDGE OF CLINICAL TRIALS REGARDING HORMONE THERAPY AND LIKELIHOOD OF PRESCRIBING HORMONE THERAPY.MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY. VOL. 24. ISSUE 1. P. 27 -34 | 25 | 86% | 1 |
10 | CANONICO, M , PLU-BUREAU, G , SCARABIN, PY , (2011) PROGESTOGENS AND VENOUS THROMBOEMBOLISM AMONG POSTMENOPAUSAL WOMEN USING HORMONE THERAPY.MATURITAS. VOL. 70. ISSUE 4. P. 354-360 | 46 | 77% | 22 |
Classes with closest relation at Level 1 |